"Replicon" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any DNA sequence capable of independent replication or a molecule that possesses a REPLICATION ORIGIN and which is therefore potentially capable of being replicated in a suitable cell. (Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed)
| Descriptor ID |
D012093
|
| MeSH Number(s) |
G05.360.340.024.745
|
| Concept/Terms |
Replicon- Replicon
- Replicons
- Replication Unit
- Replication Units
- Unit, Replication
- Units, Replication
|
Below are MeSH descriptors whose meaning is more general than "Replicon".
Below are MeSH descriptors whose meaning is more specific than "Replicon".
This graph shows the total number of publications written about "Replicon" by people in this website by year, and whether "Replicon" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2002 | 1 | 1 | 2 |
| 2004 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Replicon" by people in Profiles.
-
Balasubramanian A, Teramoto T, Kulkarni AA, Bhattacharjee AK, Padmanabhan R. Antiviral activities of selected antimalarials against dengue virus type 2 and Zika virus. Antiviral Res. 2017 01; 137:141-150.
-
Pang X, Guo Y, Zhou Y, Fu W, Gu X. Highly efficient production of a dengue pseudoinfectious virus. Vaccine. 2014 Jun 24; 32(30):3854-60.
-
Chandra PK, Kundu AK, Hazari S, Chandra S, Bao L, Ooms T, Morris GF, Wu T, Mandal TK, Dash S. Inhibition of hepatitis C virus replication by intracellular delivery of multiple siRNAs by nanosomes. Mol Ther. 2012 Sep; 20(9):1724-36.
-
Waris G, Turkson J, Hassanein T, Siddiqui A. Hepatitis C virus (HCV) constitutively activates STAT-3 via oxidative stress: role of STAT-3 in HCV replication. J Virol. 2005 Feb; 79(3):1569-80.
-
Gilmour MW, Thomson NR, Sanders M, Parkhill J, Taylor DE. The complete nucleotide sequence of the resistance plasmid R478: defining the backbone components of incompatibility group H conjugative plasmids through comparative genomics. Plasmid. 2004 Nov; 52(3):182-202.
-
Wu L, Sun M, Zhu CG, Zhang L, Yu ZN. [A novel resolution vector with Bacillus thuringiensis plasmid replicon ori44]. Sheng Wu Gong Cheng Xue Bao. 2002 May; 18(3):335-8.
-
Parks CL, Wang HP, Kovacs GR, Vasilakis N, Kowalski J, Nowak RM, Lerch RA, Walpita P, Sidhu MS, Udem SA. Expression of a foreign gene by recombinant canine distemper virus recovered from cloned DNAs. Virus Res. 2002 Feb 26; 83(1-2):131-47.
-
Balasuriya UB, Heidner HW, Davis NL, Wagner HM, Hullinger PJ, Hedges JF, Williams JC, Johnston RE, David Wilson W, Liu IK, James MacLachlan N. Alphavirus replicon particles expressing the two major envelope proteins of equine arteritis virus induce high level protection against challenge with virulent virus in vaccinated horses. Vaccine. 2002 Feb 22; 20(11-12):1609-17.
-
Balasuriya UB, Heidner HW, Hedges JF, Williams JC, Davis NL, Johnston RE, MacLachlan NJ. Expression of the two major envelope proteins of equine arteritis virus as a heterodimer is necessary for induction of neutralizing antibodies in mice immunized with recombinant Venezuelan equine encephalitis virus replicon particles. J Virol. 2000 Nov; 74(22):10623-30.
-
Nugent CI, Johnson KL, Sarnow P, Kirkegaard K. Functional coupling between replication and packaging of poliovirus replicon RNA. J Virol. 1999 Jan; 73(1):427-35.